 |
|
Study links primary insomnia to a neurochemical abnormality in young and middle-aged adults
November 03, 2008The study is the first to show a specific neurochemical difference in the brains of adults with primary insomnia
Westchester, Ill. - A study in the Nov. 1 issue of the journal Sleep is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia, providing greater insight to the limited understanding of the condition's pathology.
Results indicate that gamma-aminobutyric acid (GABA), the most common inhibitory transmitter in the brain, is reduced by nearly 30 percent in individuals who have been suffering from primary insomnia for more than six months. These findings suggest that primary insomnia is a manifestation of a neurobiological state of hyperarousal, which is present during both waking and sleep at physiological and cognitive levels.
"GABA is reduced in the brain of individuals with insomnia, suggesting overactivity is present not only at the level of excessive thoughts and emotions, but can also be detected at the level of the nervous system," said principal investigator Dr. John Winkelman of Brigham and Women's Hospital, which is a teaching affiliate of Harvard Medical School in Boston, Mass.
GABA decreases overall activity in many brain areas, helping the brain to "shut down." Having a "racing mind" and an inability to shut down at night is a common complaint of people with primary insomnia.
Chronic insomnia, or symptoms that last for at least a month, affects about 10 percent of all adults in industrialized countries and is the most common sleep disorder. Most often insomnia is a "comorbid" disorder, present with another medical illness, mental disorder or sleep disorder, or associated with certain medications or substances. Approximately 25 percent of people suffering from insomnia are considered to have primary insomnia, which is defined as a difficulty falling asleep or maintaining sleep in the absence of coexisting conditions.
According to Winkelman, the recognition that primary insomnia is associated with a specific neurochemical deficiency helps validate the often misunderstood complaint of insomnia.
"Recognition that insomnia has manifestations in the brain may increase the legitimacy of those who have insomnia and report substantial daytime consequences," he said. "Insomnia is not just a phenomenon observed at night, but has daytime consequences for energy, concentration and mood."
This preliminary study included 16 participants (eight men and eight women) who were screened to be free of medical and sleep disorders, as well as anxiety and mood disorders, and who were not taking prescription medication. Ages ranged from 25 to 55 years. Researchers recruited people who had difficulty initiating or maintaining sleep with resulting daytime distress or dysfunction for a period of at least six months. The average duration of participants' symptoms was 10 years. Objective data were collected by actigraphy and overnight polysomnography. Proton magnetic resonance spectroscopy (1H-MRS) was used to non-invasively determine GABA levels. For statistical comparison the study included a well-matched control group consisting of seven women and nine men.
Significant correlations were found between GABA levels and both subjective and objective sleep measures after adjusting for age, body mass index (BMI) and gender. In subjects with primary insomnia, sleep continuity, as measured by minutes of wake after sleep onset (WASO) on sleep study, was strongly associated with GABA levels.
According to the study, reductions in brain GABA levels also have been observed with 1H-MRS in major depressive disorder (MDD) and anxiety disorders. Primary insomnia shares many features with anxiety and depressive disorders, including sleep disturbance, elevation in anxiety, and impairments in concentration and energy. In addition, primary insomnia is an important risk factor for incident mood and anxiety disorders. The study raises the possibility that GABA deficiencies seen in people with mood and anxiety disorders may be based on disturbances in sleep.
The study also reports that many of the hypnotic medications that are most effective in treating insomnia are benzodiazepine receptor antagonists (BzRAs), which increase activity at the GABA neurons. According to a new clinical guideline for the evaluation and management of chronic insomnia in adults, which was published by the American Academy of Sleep Medicine in the Journal of Clinical Sleep Medicine, hypnotic treatment should be supplemented with behavioral and cognitive therapies whenever possible.
American Academy of Sleep Medicine
"GABA is reduced in the brain of individuals with insomnia, suggesting overactivity is present not only at the level of excessive thoughts and emotions, but can also be detected at the level of the nervous system," said principal investigator Dr. John Winkelman of Brigham and Women's Hospital, which is a teaching affiliate of Harvard Medical School in Boston, Mass.
GABA decreases overall activity in many brain areas, helping the brain to "shut down." Having a "racing mind" and an inability to shut down at night is a common complaint of people with primary insomnia.
Chronic insomnia, or symptoms that last for at least a month, affects about 10 percent of all adults in industrialized countries and is the most common sleep disorder. Most often insomnia is a "comorbid" disorder, present with another medical illness, mental disorder or sleep disorder, or associated with certain medications or substances. Approximately 25 percent of people suffering from insomnia are considered to have primary insomnia, which is defined as a difficulty falling asleep or maintaining sleep in the absence of coexisting conditions.
According to Winkelman, the recognition that primary insomnia is associated with a specific neurochemical deficiency helps validate the often misunderstood complaint of insomnia.
"Recognition that insomnia has manifestations in the brain may increase the legitimacy of those who have insomnia and report substantial daytime consequences," he said. "Insomnia is not just a phenomenon observed at night, but has daytime consequences for energy, concentration and mood."
This preliminary study included 16 participants (eight men and eight women) who were screened to be free of medical and sleep disorders, as well as anxiety and mood disorders, and who were not taking prescription medication. Ages ranged from 25 to 55 years. Researchers recruited people who had difficulty initiating or maintaining sleep with resulting daytime distress or dysfunction for a period of at least six months. The average duration of participants' symptoms was 10 years. Objective data were collected by actigraphy and overnight polysomnography. Proton magnetic resonance spectroscopy (1H-MRS) was used to non-invasively determine GABA levels. For statistical comparison the study included a well-matched control group consisting of seven women and nine men.
Significant correlations were found between GABA levels and both subjective and objective sleep measures after adjusting for age, body mass index (BMI) and gender. In subjects with primary insomnia, sleep continuity, as measured by minutes of wake after sleep onset (WASO) on sleep study, was strongly associated with GABA levels.
According to the study, reductions in brain GABA levels also have been observed with 1H-MRS in major depressive disorder (MDD) and anxiety disorders. Primary insomnia shares many features with anxiety and depressive disorders, including sleep disturbance, elevation in anxiety, and impairments in concentration and energy. In addition, primary insomnia is an important risk factor for incident mood and anxiety disorders. The study raises the possibility that GABA deficiencies seen in people with mood and anxiety disorders may be based on disturbances in sleep.
The study also reports that many of the hypnotic medications that are most effective in treating insomnia are benzodiazepine receptor antagonists (BzRAs), which increase activity at the GABA neurons. According to a new clinical guideline for the evaluation and management of chronic insomnia in adults, which was published by the American Academy of Sleep Medicine in the Journal of Clinical Sleep Medicine, hypnotic treatment should be supplemented with behavioral and cognitive therapies whenever possible.
American Academy of Sleep Medicine
Insomnia Current Events and Insomnia News RSSGreen tea shows promise as chemoprevention agent for oral cancer, M. D. Anderson study finds
Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center.
Fighting Sleep, Penn Researchers Reverse the Cognitive Impairment Caused By Sleep Deprivation
A research collaboration led by biologists and neuroscientists at the University of Pennsylvania has found a molecular pathway in the brain that is the cause of cognitive impairment due to sleep deprivation.
Exercise reduces fatigue in cancer patients undergoing chemotherapy
Supervised exercise programmes that include high and low intense cardiovascular and resistance training can help reduce fatigue in patients with cancer who are undergoing adjuvant chemotherapy or treatment for advanced disease.
U-M discovery about biological clocks overturns long-held theory
University of Michigan mathematicians and their British colleagues say they have identified the signal that the brain sends to the rest of the body to control biological rhythms, a finding that overturns a long-held theory about our internal clock.
Novel, soy-based SE5-OH containing Natural S-equol supplement reduced hot flash frequency by nearly 59 percent
SE5-OH containing Natural S-equol, a novel soy germ-based ingredient in a supplement, improved menopausal symptoms, including significantly reducing hot flash frequency by nearly 59 percent, according to a peer-reviewed study in Japanese women.
Penn studies point to strategies for reducing painful breast cancer drug side effects
Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines.
'Alert status' area in brain discoved by Hebrew University scientists
A new understanding of how anesthesia and anesthesia-like states are controlled in the brain opens the door to possible new future treatments of various states of loss of consciousness, such as reversible coma, according to Hebrew University of Jerusalem scientists.
Insomnia is bad for the heart
Can't sleep at night? A new study published in the journal Sleep has found that people who suffer from insomnia have heightened nighttime blood pressure, which can lead to cardiac problems.
Workplace bullying is associated with sleep disturbances
A study in the Sept.1 issue of the journal SLEEP shows that current or past exposure to workplace bullying is associated with increased sleep disturbances.
Chemotherapy for breast cancer is associated with disruption of sleep-wake rhythm in women
A study in the Sept.1 issue of the journal Sleep shows that the sleep-wake activity rhythms of breast cancer patients are impaired during the administration of chemotherapy.
More Insomnia Current Events and Insomnia News Articles
 |
Insomnia (Widescreen Edition) Starring: Al Pacino, Robin Williams, Hilary Swank, Oliver 'Ole' Zemen, Martin Donovan Directed By: Christopher Nolan Also With: Andrew A. Kosove (Producer), Ben Cosgrove (Producer), Broderick Johnson (Producer), Charles J.D. Schlissel (Producer), Erik Skjoldbjærg (Writer), Hillary Seitz (Writer), Nikolaj Frobenius (Writer) Crime never sleeps. Neither does Will Dormer (AL PACINO), a veteran LAPD homicide detective sent north to Alaska to head a murder case. There his investigation is disrupted by an ever-shining Midnight Sun that wreaks sleep-depriving havoc on his body clock and brings Dormer's shady, guilt-plagued past into the light of day. DVD Features: |
 |
Insomnia by Stephen King (Author) Ralph Roberts hasn't been sleeping well lately. Every morning he wakes just a little bit earlier until pretty soon, he isn't sleeping at all. It wouldn't be so bad if not for the strange hallucinations--and the nightmares that keep coming to life. |
 |
Hyland's Insomnia, 100 Tablets (Pack of 3) by Hyland's Homeopathic Homeopathic. Natural relief for insomnia and restlessness. Formerly Hyland's No. 23, Hyland's Insomnia is a traditional homeopathic formula for the relief of insomnia, sleeplessness and restlessness due to worry or stress. Working without contraindications or side effects. Hyland's Insomnia stimulates your body's natural healing response to relieve symptoms without sedative hangover. Hyland's Insomnia is safe for adults and children and can be used in conjunction with other medications. Made in USA. |
 |
Insomnia - Criterion Collection Starring: Maria Mathiesen, Stellan Skarsgård, Sverre Anker Ousdal, Gisken Armand, Kristian Figenschow Directed By: Erik Skjoldbjærg Disgraced Swedish detective Jonas Engström (Stellan Skarsgård) travels to northern Norway to solve a brutal murder in Insomnia. Unable to sleep through the night of the midnight sun, Engström quickly loses his grip on the case and his mind. Erik Skjoldbjærg's debut feature is a deft amalgam of psychological thriller, morality play, and police procedural. Criterion presents the DVD premiere of Insomnia in a new widescreen transfer. |
 |
The Insomnia Solution: The Natural, Drug-Free Way to a Good Night's Sleep by Michael Krugman (Author) Insomnia. It’s nearly universal affliction that keeps millions of Americans up at night. But now there’s help: THE INSOMNIA SOLUTION by Michael Krugman. In this revolutionary book, Krugman shows readers that insomnia is not just a nighttime affliction, but a 24-hour-a-day condition resulting from daytime stress that persists into the night, delaying the onset of sleep and making it shallower and less restful. To relieve stress and ensure sounder sleep, Krugman offers a two-pronged program of gentle, physical techniques, called Mini-Moves, based on traditional and modern self-healing methods including qigong, meditation, and the Feldenkrais Method. Brief, daytime Mini-Moves offset stress and make life more peaceful. When your life is more peaceful, your sleep is more... |
 |
Say Good Night to Insomnia by Gregg D. Jacobs (Author) The bestselling guide to curing insomnia without drugs by "a pioneer" of the field, now updated with the latest research (The Wall Street Journal) For the past ten years, sleep-deprived Americans have found natural, drug-free relief from insomnia with the help of Dr. Gregg D. Jacobs’s Say Good Night to Insomnia. Jacobs’s program, developed and tested at Harvard Medical School and based on cognitive behavioral therapy, has been shown to improve sleep long-term in 80 percent of patients, making it the gold standard for treatment. He provides techniques for eliminating sleeping pills; establishing sleep-promoting behaviors and lifestyle practices; and improving relaxation, reducing stress, and changing negative thoughts about sleep. In this updated edition, Jacobs... |
 |
Insomnia (Full Screen Edition) Starring: Al Pacino, Robin Williams, Hilary Swank, Oliver 'Ole' Zemen, Martin Donovan Directed By: Christopher Nolan Also With: Andrew A. Kosove (Producer), Ben Cosgrove (Producer), Broderick Johnson (Producer), Charles J.D. Schlissel (Producer), Erik Skjoldbjærg (Writer), Hillary Seitz (Writer), Nikolaj Frobenius (Writer) Crime never sleeps. Neither does Will Dormer (AL PACINO), a veteran LAPD homicide detective sent north to Alaska to head a murder case. There his investigation is disrupted by an ever-shining Midnight Sun that wreaks sleep-depriving havoc on his body clock and brings Dormer's shady, guilt-plagued past into the light of day. DVD Features: |
 |
Sleep Solutions (The Calming Collection) by Roberta Shapiro The first of this wonderfully helpful series is : SLEEP SOLUTIONS. Several techniques are provided, including meditation and hypnosis, which have been found to be highly effective with sleep problems and sleep management. The Calming Collection provides simple, direct solutions for dramatically reducing anxiety through the use of mindful meditation and hypnosis to more rapidly produce deep healing relaxation, profound relief of stress and anxiety and more rapid, lasting achievement of one's goals. These programs use the concept of hypno-meditation and were designed by Roberta Shapiro, M.Ed., a leading specialist in the field of anxiety management. They were formulated as a more rapid and helpful way to manage anxiety and other personal issues. Roberta Shapiro is a renowned psychotherapist... |
 |
LifeSign SleepKey Handheld Insomnia Treatment Computer by LifeSign SleepKey is a small hand-held computer that uses cognitive behavioral therapy in a self-help format to treat insomnia. SleepKey is scientifically based and its development was funded in part with grants from the National Heart, Lung, and Blood Institute of the National Institutes of Health. SleepKey works in three stages: Stage 1 (1 week): SleepKey records your sleep pattern while in bed based on your response to a low volume beep, and helps you develop a regular wake up time. Stage 2 (about 2-4 weeks): Based on your sleep pattern, SleepKey sets your bedtime and prompts you to get out of bed if not sleeping so that most of your time in bed is spent asleep. SleepKey then gradually adjusts your bedtime until you are getting a full night's sleep. Stage 3: SleepKey helps you maintain a... |
 |
Insomnia Craig David (Primary Contributor) |
| © 2009 BrightSurf.com |